Clinical Trial: To Evaluate the Safety and Efficacy of RNK08954 in Patients With Advanced Gynecological Tumors.

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07848893) titled 'To Evaluate the Safety and Efficacy of RNK08954 in Patients With Advanced Gynecological Tumors.' on Aug. 31.

Brief Summary: This is a multicenter, open-label, phase II clinical study to evaluate the safety and preliminary efficacy of RNK08954 in patients with advanced gynecological tumors

Study Start Date: Sept. 15

Study Type: INTERVENTIONAL

Condition: Advanced Gynecologic Malignancies

Intervention: DRUG: RNK08954

RNK08954 will be administered at the assigned dose level, orally, until disease progression or intolerable toxicity.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Ranok Therapuetics Co. Ltd.

Published by HT Digi...